Importantly, malaria during pregnancy constitutes a major driver of maternal and neonatal health in endemic areas. Furthermore, pregnant women with HIV infection have the highest risk for malaria and its consequences leading to even poorer maternal and infant health. The potential impact of SARS-CoV-2 infections in the context of malaria and HIV in pregnancy is still poorly understood.
The findings of this project will contribute to the understanding of the impact of SARS-CoV-2 and COVID-19 among pregnant women and guide case management strategies to improve maternal and neonatal health in SSA countries where diseases such as malaria and HIV are highly prevalent. This project is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) through an emergency call (RIA2020EF), which supports research projects in Sub-Saharan Africa in response to the COVID-19 pandemic. It has been planned a duration of 21 months (until 31st March 2023) and it will recruit about 1000 women.